Lv SQ. Correction to “Jianpi Gushen Huayu decoction ameliorated diabetic nephropathy through modulating metabolites in kidney, and inhibiting TLR4/NF-κB/NLRP3 and JNK/P38 pathways”. World J Diabetes 2026; 17(4): 119227 [DOI: 10.4239/wjd.v17.i4.119227]
Corresponding Author of This Article
Shu-Quan Lv, PhD, Chief Physician, Department of Endocrinology, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine of Hebei Province Affiliated to Hebei University of Chinese Medicine, No. 5 Xianghai Road, High-tech Zone, Cangzhou 061012, Hebei Province, China. czlvshuquan@163.com
Research Domain of This Article
Endocrinology & Metabolism
Article-Type of This Article
Correction
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Apr 15, 2026 (publication date) through Apr 14, 2026
Times Cited of This Article
Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Lv SQ. Correction to “Jianpi Gushen Huayu decoction ameliorated diabetic nephropathy through modulating metabolites in kidney, and inhibiting TLR4/NF-κB/NLRP3 and JNK/P38 pathways”. World J Diabetes 2026; 17(4): 119227 [DOI: 10.4239/wjd.v17.i4.119227]
World J Diabetes. Apr 15, 2026; 17(4): 119227 Published online Apr 15, 2026. doi: 10.4239/wjd.v17.i4.119227
Correction to “Jianpi Gushen Huayu decoction ameliorated diabetic nephropathy through modulating metabolites in kidney, and inhibiting TLR4/NF-κB/NLRP3 and JNK/P38 pathways”
Shu-Quan Lv
Shu-Quan Lv, Department of Endocrinology, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine of Hebei Province Affiliated to Hebei University of Chinese Medicine, Cangzhou 061012, Hebei Province, China
Author contributions: Lv SQ solely contributed to this paper.
Conflict-of-interest statement: The author reports no relevant conflicts of interest for this article.
Corresponding author: Shu-Quan Lv, PhD, Chief Physician, Department of Endocrinology, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine of Hebei Province Affiliated to Hebei University of Chinese Medicine, No. 5 Xianghai Road, High-tech Zone, Cangzhou 061012, Hebei Province, China. czlvshuquan@163.com
Received: January 23, 2026 Revised: February 4, 2026 Accepted: March 18, 2026 Published online: April 15, 2026 Processing time: 82 Days and 19.8 Hours
Abstract
This is a correction to the published paper titled “Jianpi Gushen Huayu decoction ameliorated diabetic nephropathy through modulating metabolites in kidney, and inhibiting TLR4/NF-κB/NLRP3 and JNK/P38 pathways”. Figure 2 is incorrect as it appears in the published version. This correction is requested to ensure the accuracy of the information presented in the article.
Core Tip: This is a correction to the article titled “Jianpi Gushen Huayu decoction ameliorated diabetic nephropathy through modulating metabolites in kidney, and inhibiting TLR4/NF-κB/NLRP3 and JNK/P38 pathways (World J Diabetes 2024; 15 (3): 502-518 PMID: 38591083 DOI: 10.4239/wjd.v15.i3.502”). Following publication, it was identified that Figure 2 contained an error due to a typesetting issue. As the corresponding author, I am submitting a corrected figure to ensure the accuracy of the information provided in this article. This correction does not impact the conclusions of the manuscript.
